Literature DB >> 7908702

Recognition of envelope protein by dengue virus serotype-specific human CD4+ CD8- cytotoxic T-cell clones.

P G Livingston1, I Kurane, C J Lai, M Bray, F A Ennis.   

Abstract

We analyzed dengue virus-specific CD4+ CD8- cytotoxic T lymphocytes (CTL) at the clonal level to further understand their role in dengue virus infections. Stimulation of peripheral blood mononuclear cells from two dengue virus type 4 (D4V)-immune donors with live D4V or noninfectious D4V antigen generated 17 HLA class II-restricted CD4+ CTL capable of specific lysis of dengue virus antigen-treated autologous lymphoblastoid cell lines. Thirteen clones were D4V specific, three clones were cross-reactive for D2V and D4V, and one clone was cross-reactive for D1V, D3V, and D4V. Antigen recognition by six D4V-specific clones and three D2V- and D4V-cross-reactive clones was restricted by HLA-DR7. Five D4V-specific CD4+ CTL clones lysed autologous lymphoblastoid cell lines infected with a dengue virus-vaccinia virus recombinant containing the E gene of D4V, whereas three serotype-cross-reactive CTL clones did not. These results indicate that E-specific clones are serotype specific and HLA-DR7 restricted in these two donors and suggest that a common epitope on E protein may be recognized. E protein-specific CD4+ CTL may be important mediators of virus clearance especially during reinfection with the same serotype as that in primary infection by providing help for virus-specific antibody production and lysis of virus-infected cells.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7908702      PMCID: PMC236818     

Source DB:  PubMed          Journal:  J Virol        ISSN: 0022-538X            Impact factor:   5.103


  31 in total

1.  Research on dengue during World War II.

Authors:  A B SABIN
Journal:  Am J Trop Med Hyg       Date:  1952-01       Impact factor: 2.345

2.  Epitopic analysis of antigenic determinants on the surface of dengue-2 virions using monoclonal antibodies.

Authors:  E A Henchal; J M McCown; D S Burke; M C Seguin; W E Brandt
Journal:  Am J Trop Med Hyg       Date:  1985-01       Impact factor: 2.345

3.  Antigen-specific interaction between T and B cells.

Authors:  A Lanzavecchia
Journal:  Nature       Date:  1985 Apr 11-17       Impact factor: 49.962

4.  Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection.

Authors:  S B Halstead; H Shotwell; J Casals
Journal:  J Infect Dis       Date:  1973-07       Impact factor: 5.226

5.  Antigen presentation by B lymphocytes: a critical step in T-B collaboration.

Authors:  A Lanzavecchia
Journal:  Curr Top Microbiol Immunol       Date:  1986       Impact factor: 4.291

6.  Expression of dengue virus structural proteins and nonstructural protein NS1 by a recombinant vaccinia virus.

Authors:  B T Zhao; G Prince; R Horswood; K Eckels; P Summers; R Chanock; C J Lai
Journal:  J Virol       Date:  1987-12       Impact factor: 5.103

7.  Identification of distinct antigenic determinants on dengue-2 virus using monoclonal antibodies.

Authors:  M K Gentry; E A Henchal; J M McCown; W E Brandt; J M Dalrymple
Journal:  Am J Trop Med Hyg       Date:  1982-05       Impact factor: 2.345

Review 8.  Pathogenesis of dengue: challenges to molecular biology.

Authors:  S B Halstead
Journal:  Science       Date:  1988-01-29       Impact factor: 47.728

9.  Monoclonal antibodies against dengue 2 virus E-glycoprotein protect mice against lethal dengue infection.

Authors:  B M Kaufman; P L Summers; D R Dubois; K H Eckels
Journal:  Am J Trop Med Hyg       Date:  1987-03       Impact factor: 2.345

10.  Lysis of dengue virus-infected cells by natural cell-mediated cytotoxicity and antibody-dependent cell-mediated cytotoxicity.

Authors:  I Kurane; D Hebblewaite; W E Brandt; F A Ennis
Journal:  J Virol       Date:  1984-10       Impact factor: 5.103

View more
  7 in total

1.  Chimeric dengue type 2 (vaccine strain PDK-53)/dengue type 1 virus as a potential candidate dengue type 1 virus vaccine.

Authors:  C Y Huang; S Butrapet; D J Pierro; G J Chang; A R Hunt; N Bhamarapravati; D J Gubler; R M Kinney
Journal:  J Virol       Date:  2000-04       Impact factor: 5.103

2.  Two complex, adenovirus-based vaccines that together induce immune responses to all four dengue virus serotypes.

Authors:  David H Holman; Danher Wang; Kanakatte Raviprakash; Nicholas U Raja; Min Luo; Jianghui Zhang; Kevin R Porter; John Y Dong
Journal:  Clin Vaccine Immunol       Date:  2006-12-27

3.  Safety and efficacy of chimeric yellow Fever-dengue virus tetravalent vaccine formulations in nonhuman primates.

Authors:  F Guirakhoo; K Pugachev; Z Zhang; G Myers; I Levenbook; K Draper; J Lang; S Ocran; F Mitchell; M Parsons; N Brown; S Brandler; C Fournier; B Barrere; F Rizvi; A Travassos; R Nichols; D Trent; T Monath
Journal:  J Virol       Date:  2004-05       Impact factor: 5.103

4.  Identification of two epitopes on the dengue 4 virus capsid protein recognized by a serotype-specific and a panel of serotype-cross-reactive human CD4+ cytotoxic T-lymphocyte clones.

Authors:  S J Gagnon; W Zeng; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-01       Impact factor: 5.103

5.  Multiple specificities in the murine CD4+ and CD8+ T-cell response to dengue virus.

Authors:  A L Rothman; I Kurane; F A Ennis
Journal:  J Virol       Date:  1996-10       Impact factor: 5.103

6.  T-cell responses to dengue virus in humans.

Authors:  Ichiro Kurane; Takaji Matsutani; Ryuji Suzuki; Tomohiko Takasaki; Siripen Kalayanarooj; Sharone Green; Alan L Rothman; Francis A Ennis
Journal:  Trop Med Health       Date:  2011-12-01

7.  Clinical outcome and genetic differences within a monophyletic Dengue virus type 2 population.

Authors:  Hapuarachchige Chanditha Hapuarachchi; Rachel Choon Rong Chua; Yuan Shi; Tun Lin Thein; Linda Kay Lee; Kim Sung Lee; David Chien Lye; Lee Ching Ng; Yee Sin Leo
Journal:  PLoS One       Date:  2015-03-26       Impact factor: 3.240

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.